author-photo

Ana Suárez-Gauthier

29

Papers

1937

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion.

2020 Future Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Abstract P4-03-16: FAPα (fibroblast activation protein-α) analysis in breast tumor cells and stroma after neoadjuvant treatment

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Accurate identification of ALK positive lung carcinoma patients: Novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (54)
The ALK translocation in advanced non-small-cell lung carcinomas: preapproval testing experience at a single cancer centre.

2013 Histopathology
Show All
- Source
- Cite
- Save
Citations (15)
A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens

2012 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (76)
EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

2012 Modern Pathology
Show All
- Source
- Cite
- Save
Citations (131)
Abstract P1-15-06: Incidence of HER2 Positive Quantified by FISH in Ductal Breast Carcinoma In Situ

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development

2009 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (244)
6652 Comparison of fluorescence in situ hybridization and dual colour chromogenic in situ hybridization for the assessment of HER2 status on gastric cancer biopsies

2009 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of fluorescence in situ hybridization and dual color chromogenic in situ hybridization for the assessment of HER2 status on core-needle breast cancer biopsies.

2009 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)